CIP
SRPT icon

Chartwell Investment Partners’s Sarepta Therapeutics SRPT Stock Holding History

Chartwell Investment Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,511
Closed -$1.75M – 438
2024
Q1 		$1.75M Buy
+13,511
New +$1.66M 0.06% 301
2021
Q2 		– Sell
-5,964
Closed -$444K – 437
2021
Q1 		$444K Sell
5,964
-413
-6% -$38.1K 0.01% 402
2020
Q4 		$1.09M Buy
6,377
+194
+3% +$28.7K 0.03% 356
2020
Q3 		$868K Sell
6,183
-1,596
-21% -$243K 0.03% 362
2020
Q2 		$1.25M Buy
7,779
+478
+7% +$65K 0.05% 311
2020
Q1 		$714K Sell
7,301
-275
-4% -$31.4K 0.03% 345
2019
Q4 		$978K Sell
7,576
-834
-10% -$84.2K 0.03% 357
2019
Q3 		$633K Sell
8,410
-180
-2% -$21.3K 0.02% 385
2019
Q2 		$1.3M Sell
8,590
-1,369
-14% -$166K 0.04% 363
2019
Q1 		$1.19M Sell
9,959
-35,804
-78% -$4.6M 0.04% 379
2018
Q4 		$4.99M Buy
45,763
+1,049
+2% +$131K 0.18% 183
2018
Q3 		$7.22M Sell
44,714
-5,531
-11% -$756K 0.21% 164
2018
Q2 		$6.64M Sell
50,245
-31,085
-38% -$2.93M 0.2% 169
2018
Q1 		$6.03M Sell
81,330
-33,712
-29% -$2.25M 0.21% 164
2017
Q4 		$6.4M Sell
115,042
-7,748
-6% -$410K 0.22% 163
2017
Q3 		$5.57M Buy
+122,790
New +$4.91M 0.19% 177

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chartwell Investment Partners's SRPT Position: Q2 2024 in Review

Chartwell Investment Partners sold out of Sarepta Therapeutics (SRPT) in Q2 2024, closing a stake of 13,511 shares — an estimated $1.75M sold.

Chartwell Investment Partners first reported a position in SRPT in Q3 2017 and held it in 16 quarters. The position peaked at $7.22M in Q3 2018. 483 funds tracked by Wall St. Rank hold SRPT as of Q2 2024.

  • Chartwell Investment Partners reported no remaining Sarepta Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Chartwell Investment Partners sold 13,511 Sarepta Therapeutics shares in Q2 2024, an estimated $1.75M.
  • Chartwell Investment Partners first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 16 quarters.
  • Chartwell Investment Partners's Sarepta Therapeutics position peaked at $7.22M in Q3 2018.
  • 483 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2024.

Based on Chartwell Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.